Understanding of ACG Clinical Guideline:Diagnosis and Management of Idiosyncratic Drug-induced Liver Injury
10.3969/j.issn.1008-7125.2015.04.001
- VernacularTitle:解读ACG临床指南：“特异质型药物性肝损伤的诊断和管理”
- Author:
Yimin MAO
- Publication Type:Journal Article
- Keywords:
Drug-Induced Liver Injury;
Idiosyncratic Drug-Induced Liver Injury;
Diagnosis;
Management;
Guideline
- From:
Chinese Journal of Gastroenterology
2015;(4):193-198
- CountryChina
- Language:Chinese
-
Abstract:
The American College of Gastroenterology( ACG)released the first clinical guideline for drug-induced liver injury( DILI)in June,2014:the diagnosis and management of idiosyncratic drug-induced liver injury( IDILI), which includes all aspects of IDILI,such as risk factors,diagnosis,differential diagnosis and treatment. The guideline discusses especially the issues on herbal and dietary supplements( HDS)induced liver injury and DILI in patients with chronic liver disease. The guideline is of great value for standardizing the clinical diagnosis and treatment,providing the best recommendations for management of the patients with DILI. Since the evidence of research in the field of DILI is relatively weak at this moment,the clinicians should consider the possible individual difference of the patients under the frame of guideline for making the best clinical decision.
